BENJAMIN RAUCHER: Open Payments
NPI 1578276689 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 50 payments from 12 companies in 2025. Trend: 2023 $444 · 2024 $1,185 · 2025 $1,208
Food & beverage: $1,208
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $273 |
| Novo Nordisk Inc | 9 | $206 |
| Astellas Pharma US Inc | 6 | $157 |
| Lilly USA, LLC | 5 | $98 |
| Merck Sharp & Dohme LLC | 4 | $95 |
| ABBVIE INC. | 4 | $94 |
| PFIZER INC. | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Optinose US, Inc. | 2 | $39 |
Products named: Veozah, AIRSUPRA, Ozempic, BREZTRI, QULIPTA, MOUNJARO, Kerendia, Xhance.
Industry payments across MD — which companies pay providers there.
